Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib

NCT03592199 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma

Interventions

DRUG: Sunitinib

Sponsor

Instituto do Cancer do Estado de São Paulo

Collaborators

[object Object]